Tradestie Institutional Equity Comparison Engine

CALI vs ABEO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABEO Overall Edge

ABEO Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Abeona Therapeutics Inc. Common Stock (ABEO) driven by superior Valuation, Growth & Margin, Options & Structure while CALI counters with relative strength in Momentum & Technical. Fundamentally, CALI trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ABEO at 18.7x Forward P/E and -186.1% operating margin (+2745.0% YoY). In options structure, CALI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ABEO sits in BREAKDOWN (27th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ABEO
CALI N/M vs ABEO 18.7x Fwd P/E
Growth & Margin Winner ABEO
Op Margin N/A vs -186.1% ยท YoY N/A vs +2745.0%
Momentum & Technical Winner CALI
1Y -0.8% vs -42.4% ยท 52W Pos 28% vs 6%
Options & Structure Winner ABEO
UNCLASSIFIED (N/A IV) vs BREAKDOWN (27th %ile IV)
CALI NASDAQ
BlackRock ETF Trust II iShares Short-Term California Muni Active ETF
Institutional Equity
$50.14
+0.1% 1D
Market Cap N/A
1M Return +-0.0%
1Y Return -0.76%
Forward P/E N/M
Unified AI Score
53.0 / 100 HOLD
Tech 65.0 Fund 52.0 Flow 50.0 Mom 60.0
ABEO NASDAQ
Abeona Therapeutics Inc. Common Stock
Pharmaceutical Preparations
$2.42
-1.22% 1D
Market Cap $167.4M
1M Return -45.86%
1Y Return -42.38%
Forward P/E 18.7x
Unified AI Score
49.9 / 100 HOLD
Tech 60.0 Fund 61.0 Flow 67.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CALI -0.76% ABEO -42.38% Spread: +41.62 pp (CALI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CALI TTM Op. Margin: N/A ABEO TTM Op. Margin: -186.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CALI vs ABEO. Trailing 12-month operating profitability (CALI N/A vs ABEO -186.1%) and valuation multiples (CALI N/M vs ABEO 18.7x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CALI (3) vs ABEO (7)
Institutional Metric CALI ABEO Criterion Row Winner
Market Capitalization Scale N/A $167.4M Larger Scale ABEO
Trailing P/E Ratio Valuation N/M 18.7x Lower Multiple ABEO
Forward P/E Ratio Valuation N/M 18.7x Lower Multiple ABEO
Revenue Growth (YoY) Growth N/A +2745.0% Higher Growth ABEO
Operating Margin (TTM) Profitability N/A -186.1% Higher Margin ABEO
Net Profit Margin Profitability N/A -160.3% Higher Margin ABEO
Return on Equity (ROE) Capital Efficiency N/A -42.1% Higher ROE ABEO
52-Week Range Position Momentum 28% ($50โ€“$51) 6% ($2โ€“$8) Stronger Trend CALI
Beta / 30D Volatility Risk Regime 0.01ฮฒ ยท 1% Vol 0.60ฮฒ ยท 149% Vol Lower Realized Risk CALI
Unified Institutional Score Composite Signal 53.0 / 100 (HOLD) 49.9 / 100 (HOLD) Higher Composite CALI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CALI vs ABEO Buy Guide
CALI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CALI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABEO BREAKDOWN
71d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 27th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ABEO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CALI nor ABEO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.